ScholarWorks@Gyeongsang National University: Rhee, Yun Seok

Detailed Information

Rhee, Yun Seok (이윤석)

약학대학 (약학과)

Research Area

Tel 0557722426
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Skin permeation:3||solid dispersion:3||Itraconazole:2||Bosentan:2||rebamipide:2||Dry powder inhalers:2||Solid dispersion:2||Pharmacokinetics:2||Transdermal patch:2||Phenol:2||Enhanced dissolution:2||Pulmonary delivery:2||solubilization:2||Eutectic mixture:2||pharmacodynamic:2||pharmacokinetic:2||Release kinetics:2||sustained release:2||Gastroretentive:2||Floating:2||Sublimation:2||3D printing:2||Microneedle:2||Crystallization:1||Dapagliflozin:1||Degenerative ocular disease:1||DfAM:1||Drug delivery:1||Druginadhesive:1||Excipients:1||Extendedrelease:1||FTIR imaging:1||Fixeddose combination tablets:1||Floating tablet:1||Galantamine:1||Gastric delivery:1||Gastric ulcer:1||Glass transition:1||Glimepiride:1||Highly porous:1||Hotmelting method:1||Humidity:1||Hydrophobic:1||Immediaterelease pellet:1||Impurities:1||In vitro:1||In vitro and in vivo characteristics:1||In vivo:1||In vivo bioavailability:1||In vivo oral bioavailability:1||Lleucine:1||Lactose:1||Matrix type controlledrelease microparticles:1||Metformin:1||Metformin hydrochloride:1||Microenvironmental pH:1||Monocrotaline:1||Nearinfrared spectroscopy:1||Nicorandil:1||Nucleic acid:1||Ocular:1||Oleic acid:1||PLGA microspheres:1||Particle image velocimetry:1||Percolation:1||Percolation threshold:1||Pharmacokinetic:1||Physicochemical properties:1||Poloxamer:1||Poorly watersoluble drug:1||Porous:1||Posterior segment:1||Powder rheometer:1||Pramipexole dihydrochloride:1||Pregelatinized starch:1||Precipitation and crystallisation:1||Preformulation:1||Pulmonary arterial hypertension:1||Rebamipide:1||Rotigotine:1||Rumex acetosa:1||Selfemulsifying solid dispersion:1||Selfnanoemulsifying solid dispersion:1||Skin irritation:1||Skin permeation rate:1||Solid oral dosage forms:1||Solidstate:1||Solubility:1||Solubility improvement:1||Spray drying:1||Spraydrying:1||Stability test:1||Storage stability:1||Swelling:1||Tacrolimus:1||Telmisartan:1||Temperature:1||Thermal analysis:1||Topical:1||Topical solution:1||Transfer:1||Twin screw granulation:1||Vaccination:1||acrylatemethacrylate copolymer:1||antiinflammatory and analgesic effects:1||atorvastatin calcium:1||bilayer tablet:1||biopharmaceutics classification system:1||bosentan:1||chitosan:1||cocrystal:1||controlled release:1||dermal drug delivery systems:1||design of experiment:1||dissolving microneedles:1||donepezil:1||doublelayer tablet:1||doublelayered microparticles:1||doxazosin mesylate:1||dry powder inhalations:1||encapsulation:1||erosion property:1||ethylcellulose:1||extrusionspheronization:1||ezetimibe:1||fesoterodine fumarate:1||fixeddose combination:1||fluidbed coating:1||fluidizedbed coating:1||gastrofloating system:1||gastroretentive tablet:1||hotmelt extrusion:1||ibuprofen:1||immediate release:1||in vitroin vivo correlation:1||in vivo drug release:1||jet milling:1||ketoprofen:1||mRNA:1||miniature pigs:1||mirabegron:1||mixture design:1||nocturnal enuresis:1||oleic acid:1||oral administration:1||oral delivery:1||orally disintegrating tablet:1||pH dependent:1||pHmodulated solid dispersion:1||pellet:1||personalized medication:1||pharmaceutical manufacturing:1||pharmacokinetic simulation:1||pharmacokinetics:1||physicochemical property:1||polypeptide/protein drug delivery:1||polyvinyl pyrrolidone:1||porous matrix:1||pulmonary arterial hypertension:1||quality by design:1||recrystallization:1||respiratory drug delivery:1||selfmicroemulsifying drug delivery system:1||siRNA:1||single depot injection:1||sitespecific drug delivery:1||solidstate characterization:1||spray drying:1||stability:1||sucrose beads:1||surface enrichment:1||swelling property:1||tamsulosin hydrochloride:1||tastemasking effectiveness:1||Aceclofenac:1||Active film coating:1||Additive manufacturing:1||Alkalizer:1||Alzheimer's disease:1||Amorphism:1||Antiinflammatory activity:1||Antioxidant activity:1||Aqueous active coating process:1||Batch process:1||Bioavailability:1||Calu3 cells:1||Carrier:1||Carrierfree DPI:1||Celecoxib:1||Chitosanbased filmforming gel:1||Cilostazol:1||Continuous process:1||Controlled release:1||Controlled release formulation:1||Controlled release tablet:1||Crystal growth rate:1||

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE